Showing 1 - 1 results of 1 for search 'Lanzi Ou', query time: 0.02s Refine Results
  1. 1
    Case Report: Durable partial response to icotinib plus crizotinib in a lung adenocarcinoma patient with double uncommon EGFR G719D/L861Q mutations and an acquired novel CUX1-MET fusion

    Case Report: Durable partial response to icotinib plus crizotinib in a lung adenocarcinoma patient with double uncommon EGFR G719D/L861Q mutations and an acquired novel CUX1-MET fu... by Lanzi Ou, Lanzi Ou, Yicong Tang, Yanming Deng, Lijie Guo, Qingqing He, Tingting He, Weineng Feng

    Published 2022-07-01
    Get full text
    Article

Search Tools: